Therapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction-Associated Fatty Liver Disease: Randomized Controlled Trial.

ABSTRACT:

Background

For patients with metabolic dysfunction-associated fatty liver disease (MAFLD), weight loss is advised but challenging in practice. In China, there is a pronounced shortage of tailored digital lifestyle interventions for this population.

Objective

This study aimed to assess the effects of a WeChat mini-program-delivered lifestyle intervention on weight loss and hepatic steatosis among individuals with MAFLD who were overweight or obese.

Methods

Adults who are overweight or obese and have clinically diagnosed MAFLD with transient elastography examination were enrolled in this prospective randomized controlled trial. Patients were randomly assigned to receive either WeChat mini-program management (intervention group) or standard care (control group) at a 1:1

SUBMITTER: Sun C 

PROVIDER: S-EPMC12843888 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature